NEW YORK, NY / ACCESSWIRE / October 5, 2020 / Transatlantic Capital Inc. (OTC PINK:TACI), an emerging diversified investment vehicle focused on three key industries, today issued a Special Letter to Shareholders summarizing its recent accomplishments and, more importantly, outlining the bright future the Company believes is on the horizon for its clients, partners, employees and most importantly, its shareholders. The content of the letter is as followed:

“Dear Fellow Shareholders,

We are more excited than ever about the growth prospects that we see for TACI, as we continue to execute our global growth strategy. Through our creative process and innovative thinking, we believe that we have carved ourselves several lucrative niches in the worldwide marketplace, mainly being our ability to provide what that world needs’ food, water, and shelter, ’new business models across three industries that will never die. More specifically, establishing ourselves in markets where growth is almost

Read More

Video: Fed’s Barkin Expects Strong U.S. Growth in Third Quarter (Bloomberg)

Fed’s Barkin Expects Strong U.S. Growth in Third Quarter

UP NEXT

UP NEXT

Markets will continue to watch for COVID-19 developments in many shapes and forms over the next week, as well as looking for how key data releases tell the story of the economic rebound.



a sign on the side of the street: A man wearing a face mask or covering due to the COVID-19 pandemic, stands at a road crossing near a sign alerting pedestrians to social distance to help mitigate the spread of COVID-19 in Liverpool, north west England on October 2, 2020, following the announcement of new local restrictions for certain areas in the northwest of the country, due to a resurgence of novel coronavirus cases. - The British government on Thursday extended lockdowns to Liverpool and several other towns in northern England, effectively putting more than a quarter of the country under tighter coronavirus restrictions. Health Secretary Matt Hancock said limits on social gatherings would be extended to the Liverpool City region, which has a population of about 1.5 million. (Photo by Oli SCARFF / AFP) (Photo by OLI SCARFF/AFP via Getty Images)


A man wearing a face mask or covering due to the COVID-19 pandemic, stands at a road crossing near a sign alerting pedestrians to social distance to help mitigate the spread of COVID-19 in Liverpool, north west England on October 2, 2020, following the announcement of new local restrictions for certain areas in the northwest of the country, due to a resurgence of novel coronavirus cases. – The British government on Thursday extended lockdowns to Liverpool and several other towns in northern England, effectively putting more than a quarter of the country

Read More

By Hideyuki Sano

TOKYO, Sept 28 (Reuters)The dollar hovered near a two-month peak against at a basket of currencies on Monday as investors look to a barrage of upcoming economic data and political developments in the United States before making any fresh bets on the U.S. currency.

While a rebound in U.S. stocks on Friday has helped to curb the ascent of the dollar, deemed as a safe-haven, signs of slowdown in the nascent economic recovery and political uncertainties have kept investors on guard.

The dollar index stood at 95.544 =USD. Last week it hit a two-month high of 94.745 last week and posted its biggest weekly rise since early April.

The euro changed hands at $1.1635 EUR=, having dropped to $1.16125 on Friday to its lowest level in two months.

The British pound stood at $1.2767 GBP=D4, slightly above Wednesday’s two-month low of

Read More

By Hideyuki Sano

TOKYO (Reuters) – The dollar hovered near a two-month peak against at a basket of currencies on Monday as investors look to a barrage of upcoming economic data and political developments in the United States before making any fresh bets on the U.S. currency.

While a rebound in U.S. stocks on Friday has helped to curb the ascent of the dollar, deemed as a safe-haven, signs of slowdown in the nascent economic recovery and political uncertainties have kept investors on guard.

The dollar index stood at 95.544 <=USD>. Last week it hit a two-month high of 94.745 last week and posted its biggest weekly rise since early April.

The euro changed hands at $1.1635 <EUR=>, having dropped to $1.16125 on Friday to its lowest level in two months.

The British pound stood at $1.2767 <GBP=D4>, slightly above Wednesday’s two-month low of $1.2676.

Data on U.S. currency futures

Read More

Just because thousands of sports fans aren’t crowding into the American Airlines Center doesn’t mean things are quiet at Victory Park.

Two of Dallas’ biggest construction projects are underway in the development on the northwest corner of downtown.

The most visible of the construction jobs is Hillwood’s new Victory Commons office — a 15-story, 365,000-square-foot building that’s the biggest office project going up on the north side of downtown.

The Victory Commons office and the 39-story Victor apartment tower going up across the street are rising on two of the last vacant sites in the 75-acre Victory Park development.

Hillwood and its partner USAA Real Estate plan to have the office building ready to open for the first tenants in November 2021.

By then, the developer plans to have the project primed for the post-COVID-19 world.

“We are on time and on budget,” said Ken Reese, executive vice president of

Read More

AstraZeneca drew headlines Tuesday with an announcement that it is beginning Phase 1 trials of its monoclonal antibody treatment for COVID-19, while American Airlines said it would be laying off 19,000 employees by Oct. 1.

AstraZeneca’s AZD7442 antibody treatment uses antibodies from patients that have been infected with COVID-19 to treat and prevent the progression of the virus.

The trials by AstraZeneca are being conducted in the U.K. with 48 healthy patients aged 18-55 through funding by the Defense Advanced Research Projects Agency of the U.S. Department of Defense and the Biomedical Advanced Research and Development Authority.

Following Phase 1 trials, AstraZeneca said it would move to larger, late-stage Phase 2 and Phase 3 trials if the results prove tolerable and favorable. Data is expected to be available in the second half of 2020.

“This trial is an important milestone in the development of our monoclonal antibody combination to prevent

Read More